CAPTRUST Financial Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-17,624
| Closed | -$11K | – | 4741 |
|
|
2022
Q2 | $11K | Buy |
17,624
+11,334
| +180% | +$7.07K | ﹤0.01% | 3721 |
|
|
2022
Q1 | $4K | Hold |
6,290
| – | – | ﹤0.01% | 4316 |
|
|
2021
Q4 | $4K | Hold |
6,290
| – | – | ﹤0.01% | 4228 |
|
|
2021
Q3 | $8K | Sell |
6,290
-1,500
| -19% | -$1.91K | ﹤0.01% | 3775 |
|
|
2021
Q2 | $11K | Hold |
7,790
| – | – | ﹤0.01% | 3523 |
|
|
2021
Q1 | $12K | Buy |
7,790
+2,938
| +61% | +$4.53K | ﹤0.01% | 3356 |
|
|
2020
Q4 | $7K | Buy |
4,852
+190
| +4% | +$274 | ﹤0.01% | 2736 |
|
|
2020
Q3 | $3K | Buy |
4,662
+2,500
| +116% | +$1.61K | ﹤0.01% | 2714 |
|
|
2020
Q2 | $1K | Buy |
+2,162
| New | +$1K | ﹤0.01% | 2797 |
|
|
2019
Q4 | – | Sell |
-6,000
| Closed | -$1K | – | 2101 |
|
|
2019
Q3 | $1K | Hold |
6,000
| – | – | ﹤0.01% | 1904 |
|
|
2019
Q2 | $2K | Sell |
6,000
-3,200
| -35% | -$1.07K | ﹤0.01% | 1839 |
|
|
2019
Q1 | $3K | Buy |
+9,200
| New | +$3K | ﹤0.01% | 1666 |
|